Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations
By: Amish S. Dave and Miguel Valderrábano
References
- Connolly SJ , Ezekowitz MD , Yusuf S , .; RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17; 361 12: 1139– 51.
- Patel MR , Mahaffey KW , Garg J , Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8; 365 10: 883– 91.
- Granger CB , Alexander JH , McMurray JJ , Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15; 365 11: 981– 92.
- Giugliano RP , Ruff CT , Braunwald E , .; ENGAGE AF-TIMI 48 Investigators Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28; 369 22: 2093– 104.
- Blackshear JL Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996 Feb; 61 2: 755– 9.
- Miller VT , Rothrock JF , Pearce LA , Feinberg WM , Hart RG , Anderson DC. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology. 1993 Jan; 43 1: 32– 6.
- Gage BF , Waterman AD , Shannon W , Boechler M , Rich MW , Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13; 285 22: 2864– 70.
- Lip GY , Nieuwlaat R , Pisters R , Lane DA , Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 Feb; 137 2: 263– 72.
- Fuster V , Rydén LE , Cannom DS , 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011 Mar 15; 57 11: e101– 98.
- Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc. 1949 Jul 2; 140 9: 769– 72.
- Healey JS , Crystal E , Lamy A , Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005 Aug; 150 2: 288– 93.
- Kanderian AS , Gillinov AM , Pettersson GB , Blackstone E , Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008 Sep 9; 52 11: 924– 9.
- Chatterjee S , Alexander JC , Pearson PJ , Feldman T. Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences. Ann Thorac Surg. 2011 Dec; 92 6: 2283– 92.
- Katz ES , Tsiamtsiouris T , Applebaum RM , Schwartzbard A , Tunick PA , Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000 Aug; 36 2: 468– 71.
- Dawson AG , Asopa S , Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg. 2010 Feb; 10 2: 306– 11.
- García-Fernández MA , Pérez-David E , Quiles J , Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003 Oct 1; 42 7: 1253– 8.
- Whitlock R , Healey J , Vincent J , Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg. 2014 Jan; 3 1: 45– 54.
- Fumoto H , Gillinov AM , Ootaki Y , A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device. J Thorac Cardiovasc Surg. 2008 Oct; 136 4: 1019– 27.
- Ailawadi G , Gerdisch MW , Harvey RL , Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011 Nov; 142 5: 1002– 9, 1009.e1.
- Benussi S , Mazzone P , Maccabelli G , Thoracoscopic appendage exclusion with an atriclip device as a solo treatment for focal atrial tachycardia. Circulation. 2011 Apr 12; 123 14: 1575– 8.
- Sievert H , Lesh MD , Trepels T , Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002 Apr 23; 105 16: 1887– 9.
- Block PC , Burstein S , Casale PN , Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv. 2009 Jul; 2 7: 594– 600.
- Holmes DR , Reddy VY , Turi ZG , Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009 Aug 15; 374 9689: 534– 42.
-
Holmes
DR
Jr , Kar S , Price MJ , Prospective randomized evaluation of the WATCHMAN Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014 Jul 8; 64 1: 1– 12. - Fuster V , Rydén LE , Cannom DS , ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Aug 15; 114 7: e257– 354.
- Reddy VY , Doshi SK , Sievert H , Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013 Feb 12; 127 6: 720– 9.
- Reddy VY , Doshi S , Sievert H , Long term results of PROTECT AF: The mortality effects of left atrial appendage closure versus warfarin for stroke prophylaxis in AF. Heart Rhythm. 2013; 10: E1412.
- Alli O , Doshi S , Kar S , Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation. J Am Coll Cardiol. 2013 Apr 30; 61 17: 1790– 8.
-
Holmes
DR
Jr , Doshi SK , Kar S , Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol. 2015 Jun 23; 65 24: 2614– 23. - Reddy VY , Holmes D , Doshi SK , Neuzil P , Kar S. Safety of percutaneous left atrial appendage closure: results from the WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011 Feb 1; 123 4: 417– 24.
- Price MJ , Reddy VY , Valderrábano M , Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. JACC Cardiovasc Interv. 2015 Dec 28; 8 15: 1925– 32.
- Reddy VY , Möbius-Winkler S , Miller MA , Left atrial appendage closure with the WATCHMAN device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013 Jun 25; 61 25: 2551– 6.
- Enomoto Y , Gadiyaram VK , Gianni C , Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the WATCHMAN device. Heart Rhythm. 2017 Jan; 14 1: 19– 24.
- Boersma LV , Schmidt B , Betts TR , Implant success and safety of left atrial appendage closure with the WATCHMAN device: periprocedural outcomes from the EWOLUTION registry. Eur Heart J. 2016 Aug; 37 31: 2465– 74.
- Reddy VY , Gibson DN , Kar S , Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. J Am Coll Cardiol. 2017 Jan 24; 69 3: 253– 61.
- Park JW , Bethencourt A , Sievert H , Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011 Apr 1; 77 5: 700– 6.
- Kleinecke C , Park JW , Gödde M , Zintl K , Schnupp S , Brachmann J. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet. Cardiol J. 2017; 24 2: 131– 8.
- Abualsaud A , Freixa X , Tzikas A , Side-by-Side Comparison of LAA Occlusion Performance With the Amplatzer Cardiac Plug and Amplatzer Amulet. J Invasive Cardiol. 2016 Jan; 28 1: 34– 8.
- Lam YY , Yip GW , Yu CM , Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012 Apr 1; 79 5: 794– 800.
- Meerkin D , Butnaru A , Dratva D , Bertrand OF , Tzivoni D. Early safety of the Amplatzer Cardiac Plug™ for left atrial appendage occlusion. Int J Cardiol. 2013 Oct 9; 168 4: 3920– 5.
- Urena M , Rodés-Cabau J , Freixa X , Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013 Jul 9; 62 2: 96– 102.
- Guérios EE , Schmid M , Gloekler S , Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol. 2012 Jun; 98 6: 528– 36.
- Streb W , SzymaŁa M , Kukulski T , Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility. Kardiol Pol. 2013; 71 1: 8– 16.
- Lee RJ , Bartus K , Yakubov SJ. Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine models. Circ Cardiovasc Interv. 2010 Jun 1; 3 3: 224– 9.
- Bartus K , Han FT , Bednarek J , Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013 Jul 9; 62 2: 108– 18.
- Bartus K , Bednarek J , Myc J , Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm. 2011 Feb; 8 2: 188– 93.
- Massumi A , Chelu MG , Nazeri A , Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013 Mar 15; 111 6: 869– 73.
- Price MJ , Gibson DN , Yakubov SJ , Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol. 2014 Aug 12; 64 6: 565– 72.
- Miller MA , Gangireddy SR , Doshi SK , Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. Heart Rhythm. 2014 Nov; 11 11: 1853– 9.
- U. S. Food & Drug Administration [Internet]. Silver Spring, MD: U.S. Food & Drug Administration; c2015. Use of LARIAT Suture Delivery Device for Left Atrial Appendage Closure: FDA Safety Communication; 2015 Jul 13 [cited 2017 May 5]. Available from: https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454501.htm.
- Giedrimas E , Lin AC , Knight BP. Left atrial thrombus after appendage closure using LARIAT. Circ Arrhythm Electrophysiol. 2013 Aug; 6 4: e52– 3.
- Briceno DF , Fernando RR , Laing ST. Left atrial appendage thrombus post LARIAT closure device. Heart Rhythm. 2014 Sep; 11 9: 1600– 1.
- Baker MS , Paul Mounsey J , Gehi AK , Chung EH. Left atrial thrombus after appendage ligation with LARIAT. Heart Rhythm. 2014 Aug; 11 8: 1489.
- Koranne KP , Fernando RR , Laing ST. Left atrial thrombus after complete left atrial appendage exclusion with LARIAT device. Catheter Cardiovasc Interv. 2015 Feb 1; 85 2: E54– 7.
- Truesdell AG , Patel CP , Maini BS. Late-occurring left atrial appendage thrombus after ligation using LARIAT. J Interv Card Electrophysiol. 2014 Oct; 41 1: 101.
- Lam YY , Yan BP , Doshi SK , Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model. Int J Cardiol. 2013 Oct 9; 168 4: 3996– 4001.
- Lam YY. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. Cardiovasc Revasc Med. 2013 May–Jun; 14 3: 134– 6.
- Friedman PA , Asirvatham SJ , Dalegrave C , Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol. 2009 Aug; 20 8: 908– 15.
- Bruce CJ , Asirvatham SJ , McCaw T , Novel percutaneous left atrial appendage closure. Cardiovasc Revasc Med. 2013 May–Jun; 14 3: 164– 7.
- Toumanides S , Sideris EB , Agricola T , Moulopoulos S. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2011 Nov 15; 58 21: 2236– 40.
- Bellmann B , Schnupp S , Kühnlein P , Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome. J Cardiovasc Electrophysiol. 2017 Mar; 28 3: 315– 20.
- Federal Institute for Drugs and Medical Devices [Internet]. Bonn, Germany: Federal Institute for Drugs and Medical Devices; c2016. Field Corrective Actions - Recall of LAA Occluder, Occlutech International AB; 2016 Oct 14 [cited 2017 May 5]. Available from: http://www.bfarm.de/SharedDocs/Kundeninfos/EN/11/2016/08384_16_Kundeninfo_en.html.
- Sabiniewicz R , Hiczkiewicz J , Wańczura P , Stecko W , Curzytek A. First-in-human experience with the Cardia Ultraseal left atrial appendage closure device: The feasibility study. Cardiol J. 2016; 23 6: 652– 4.
- Valderrabano M Price MJ. Percutaneous left atrial appendage ligation for stroke prevention in atrial fibrillation. Methodist DeBakey Cardiovasc J. 2015 Apr–Jun; 11 2: 94– 9.
DOI: https://doi.org/10.14797/mdcj-13-3-106 | Journal eISSN: 1947-6108
Language: English
Page range: 106 - 113
Published on: Jul 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2017 Amish S. Dave, Miguel Valderrábano, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.